72 related articles for article (PubMed ID: 11498990)
1. [Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell].
Yuan Y; Xu DL; Liu YL; Jia MY
Sheng Li Xue Bao; 1999 Jun; 51(3):285-90. PubMed ID: 11498990
[TBL] [Abstract][Full Text] [Related]
2. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
3. [Different expressions of cyclins and cyclin dependent kinase inhibitor P27 in vascular smooth muscle cells and cardiac myocytes caused by angiotensin II and PDGF stimulation].
Xu D; Yuan Y; Liu Y
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):657-60. PubMed ID: 11715452
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms.
Servant MJ; Coulombe P; Turgeon B; Meloche S
J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
Rao GN
Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305
[TBL] [Abstract][Full Text] [Related]
6. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ
J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of cyclin-dependent kinase inhibitors by mitogen-activated protein kinase in angiotensin II-stimulated vascular smooth muscle cell hypertrophy].
Liu Y; Xu DL; Wang MH; Ouyang P; Lai WY
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):114-6. PubMed ID: 12390801
[TBL] [Abstract][Full Text] [Related]
8. PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells.
Sakakibara K; Kubota K; Worku B; Ryer EJ; Miller JP; Koff A; Kent KC; Liu B
J Biol Chem; 2005 Jul; 280(27):25470-7. PubMed ID: 15894805
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
10. Effects of dominant-negative c-Jun on platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
Zhan Y; Kim S; Yasumoto H; Namba M; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):82-8. PubMed ID: 11788465
[TBL] [Abstract][Full Text] [Related]
11. [Effects of human tissue kallikrein gene delivery on the proliferation of vascular smooth muscle cells].
Zhu PL; Yu HZ; Xie LD; Ruan JM; Xu CS; Li TY
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):739-44. PubMed ID: 21055144
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
Cospedal R; Lobo M; Zachary I
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth.
Mueller C; Baudler S; Welzel H; Böhm M; Nickenig G
Circulation; 2002 May; 105(20):2423-8. PubMed ID: 12021231
[TBL] [Abstract][Full Text] [Related]
14. Gleditsia sinensis thorn extract inhibits the proliferation and migration of PDGF‑induced vascular smooth muscle cells.
Park SS; Kim WJ; Moon SK
Mol Med Rep; 2014 Oct; 10(4):2031-8. PubMed ID: 25069874
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.
Campos AH; Wang W; Pollman MJ; Gibbons GH
Circ Res; 2002 Nov; 91(11):999-1006. PubMed ID: 12456485
[TBL] [Abstract][Full Text] [Related]
16. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
18. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
Haider A; Lee I; Grabarek J; Darzynkiewicz Z; Ferreri NR
Circulation; 2003 Aug; 108(8):1015-21. PubMed ID: 12912810
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1.
Wolf G; Jablonski K; Schroeder R; Reinking R; Shankland SJ; Stahl RA
Kidney Int; 2003 Jul; 64(1):71-81. PubMed ID: 12787397
[TBL] [Abstract][Full Text] [Related]
20. Dahuang zhechong pill containing serum inhibited platelet-derived growth factor-stimulated vascular smooth muscle cells proliferation by inducing G1 arrest partly via suppressing protein kinase C α-extracellular regulated kinase 1/2 signaling pathway.
Liu N; Liu JT; Ji YY; Lu PP
Chin J Integr Med; 2012 May; 18(5):371-7. PubMed ID: 21533776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
